BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 13, 2010
View Archived Issues
Albert Einstein College of Medicine claims hypoxia-targeted agents
Read More
Effect of citalopram on drinking depends on goals of alcohol-dependent subjects
Read More
RespiVert claims MAPK p38 inhibitors
Read More
AstraZeneca discovers new inhibitors of DAT and NET
Read More
Histamine H3 receptor ligands claimed by Merck & Co.
Read More
Merck & Co. claims new glucagon receptor antagonists
Read More
Nerviano describes new B-raf kinase inhibitors
Read More
BHT-3021 shows promise in phase I/II trial in type 1 diabetes
Read More
Weekly rituximab reduces proteinuria in idiopathic membranous nephropathy
Read More
Exelixis presents preclinical data on agents investigated for diabetes
Read More
Viamet describes new cytochrome P450-C17 inhibitors
Read More
Western States Biopharma and University of Colorado to develop TCISM-targeting agents
Read More
Selvita and Orion collaborate on SEL-103 program in AD
Read More
KAEL-GemVax reports phase III data on tertomotide in pancreatic cancer
Read More
Imiquimod superior to placebo in phase III program for external genital warts
Read More
Results reported from phase II study of gemcitabine/Amplimexon in pancreatic cancer
Read More
Midatech and Immunotope join to form Syntara to develop immune therapies
Read More
Adimab and Novartis partner after launch of antibody discovery platform
Read More
Interim phase IIb data reported on TMC-435 in HCV infection
Read More
FDA accepts Protalix's NDA for taliglucerase alfa
Read More
Hemispherx reports on Japanese trials of nasal H5N1 vaccine
Read More
JDRF awards Biodel grants for its VIAject diabetes therapy
Read More
Mesoblast and FDA to discuss phase III program for bone marrow regeneration
Read More
Quest PharmaTech forms clinical advisory panel for oregovomab
Read More
Clinuvel reports on phase III trial of Scenesse in EPP
Read More
